<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03717753</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0814</org_study_id>
    <nct_id>NCT03717753</nct_id>
  </id_info>
  <brief_title>Rotator Cuff Pathway</brief_title>
  <official_title>The Association Between a Comprehensive Multimodal Pathway And Pain 0-48 Hours After Arthroscopic Rotator Cuff Repair: A Before-and After Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rotator cuff surgery is mostly performed on an outpatient basis, and many patients still
      experience moderate to severe pain after surgery, despite the use of regional anesthesia and
      opioids. The specific aim is to determine whether a comprehensive pathway that includes a
      well-defined regional technique and multimodal analgesia will reduce the worst pain with
      movement 0-48 hours after block placement compared to the current standard practice. This is
      a 'before and after' study. We plan to have 70 patients studied prior to initiation of a
      pathway, and 70 patients studied after initiation of a pathway. Both groups will receive
      identical postoperative follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 7, 2018</start_date>
  <completion_date type="Anticipated">September 7, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Outcome - Worst NRS with movement</measure>
    <time_frame>0-48 hours after block placement</time_frame>
    <description>worst NRS with movement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Opioid Use</measure>
    <time_frame>Post Op Days 1,2,7,14</time_frame>
    <description>Total Opioid Use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With Pain Management on scale 0-10</measure>
    <time_frame>Post Op Days 1,2,7,14</time_frame>
    <description>Satisfaction with Pain Management</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score at Rest</measure>
    <time_frame>Post Op Days 1,2,7,14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block Duration</measure>
    <time_frame>Through Post Op Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selected Patient Oriented Pain Questionnaire</measure>
    <time_frame>Post Op Days 1,2,7,14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and Physician Adherence to Pathway</measure>
    <time_frame>Post Op Days 1,2,7,14</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Shoulder Pain</condition>
  <arm_group>
    <arm_group_label>Before Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>We plan to have 70 patients studied prior to initiation of a pathway.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>After Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We plan to have 70 patients studied after initiation of a pathway.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pathway</intervention_name>
    <description>The study team emphasizes that all components of the pathway are considered standard of care at this institution. The objective of this study is to ensure that the study patients assigned to the pathway will receive these standard of care components.</description>
    <arm_group_label>After Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory rotator cuff patients with participating surgeons.

        Includes the following concomitant procedures:

          -  Arthroscopic SLAP (Superior Labrum Anterior and Posterior) repair

          -  Arthroscopic Stabilization

          -  Arthroscopic AC (Acromioclavicular) resection

          -  Arthroscopic SAD (Sub-Acromial Decompression)

          -  Arthroscopic or mini open biceps tenodesis

          -  Age 18-80

        Exclusion Criteria:

          -  chronic pain history (defined as use of opioids &gt; 3 months or current gabapentinoids
             for pain)

          -  open surgery (but sub pectoralis mini open biceps tenodesis is not excluded)

          -  revision surgery

          -  kidney disease (GFR &lt; 60 ml/min/1.73 m2 for 3 months or more)

          -  liver disease (transaminitis, cirrhosis, hepatitis, hypoalbuminemia, coagulopathy)

          -  planned avoidance of regional anesthesia

          -  any contraindication to or patient refusal of any component in the pathway

          -  Non-English speakers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques YaDeau</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2018</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

